BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

CUSIP: 07782B104

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Ordinary Shares, par value US$0.0001 per share
Shares outstanding
37,379,062
Total 13F shares
58,112
Share change
-96,997
Total reported value
$2,229,758
Price per share
$38.37
Number of holders
11
Value change
-$4,083,463
Number of buys
2
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q1 2024

As of 31 Mar 2024, BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,112 shares. The largest 10 holders included STATE STREET CORP, MARSHALL WACE, LLP, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Cubist Systematic Strategies, LLC, Virtus ETF Advisers LLC, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, and GAMMA Investing LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.